Housey Pharm., Inc. v. Astrazeneca Uk Ltd., 543 U.S. 1096 (2005). · Go Syfert
Search
Housey Pharm., Inc. v. Astrazeneca Uk Ltd., 543 U.S. 1096 (2005). Cases Citing This Book View Copy Cite
8 citation events (8 in the last 25 years) across 5 distinct courts.
Strongest positive: Walker v. Woodford (casd, 2006-09-12)
Top citers, strongest first. 4 distinct citers. How cited ↗
discussed Cited "see" Walker v. Woodford
S.D. Cal. · 2006 · signal: see · confidence high
See Beardslee v. Woodford, 395 F.3d 1064, 1067 (9th Cir.), cert. denied, 543 U.S. 1096 , 125 S.Ct. 982 , 160 L.Ed.2d 910 (2005); Arcamuzi v. Continental Air Lines, Inc., 819 F.2d 935, 937 (9th Cir.1987).
discussed Cited "see, e.g." Michael Taylor v. Larry Crawford etc.
8th Cir. · 2007 · signal: see also · confidence low
Lethal injection itself “is commonly thought to be the most humane form of execution.” Abdur’Rahman v. Bredesen, 181 S.W.3d 292, 306 (Tenn.2005), cert. denied, — U.S. -, 126 S.Ct. 2288 , 164 L.Ed.2d 813 (2006); see also Beardslee v. Woodford, 395 F.3d 1064, 1074 (9th Cir.) (specifically noting that humane concerns were a motivation for adopting lethal injection as the presumptive method of execution in California), cer t. denied, 543 U.S. 1096 , 125 S.Ct. 982 , 160 L.Ed.2d 910 (2005).
discussed Cited "see, e.g." Taylor v. Crawford
8th Cir. · 2007 · signal: see also · confidence low
Lethal injection itself "is commonly thought to be the most humane form of execution." Abdur'Rahman v. Bredesen, 181 S.W.3d 292, 306 (Tenn.2005), cert. denied, ___ U.S. ___, 126 S.Ct. 2288 , 164 L.Ed.2d 813 (2006); see also Beardslee v. Woodford, 395 F.3d 1064, 1074 (9th Cir.) (specifically noting that humane concerns were a motivation for adopting lethal injection as the presumptive method of execution in California), cert. denied, 543 U.S. 1096 , 125 S.Ct. 982 , 160 L.Ed.2d 910 (2005).
discussed Cited "see, e.g." Bieghler v. State
Ind. · 2005 · signal: see, e.g. · confidence low
See, eg., Beardslee v. Woodford, 395 F.3d 1064, 1076 (9th Cir.2005), cert. denied, 548 U.S. 1096 , 125 S.Ct. 982 , 160 L.Ed.2d 910 (2005); Cooper v. Rimmer, 379 F.3d 1029, 1031-83 (9th Cir.2004); Reid v. Johnson, 388 F.Supp.2d 548, 552-58 (E.D.Va.2004); State v. Webb, 252 Conn. 128 , 750 A.2d 448, 454-56 (2000), cert. denied, 531 U.S. 885 , 121 S.Ct. 98 , 148 L.Ed.2d 53 (2000); Sims v. State, 754 So.2d 657, 666-68 (Fla.2000), cert. denied, 528 U.S. 1188 , 120 S.Ct. 12833 , 145 L.Ed.2d 1122 (2000); Morrow v. State, 21 S.W.3d 819, 828 (Mo.2000), cert. denied 531 U.S. 1171 , 121 S.Ct. 1140 , 148 …
Retrieving the full opinion text from the archive…
Housey Pharmaceuticals, Inc.
v.
Astrazeneca UK Ltd. Et Al.
04-695.
Supreme Court of the United States.
Jan 18, 2005.
543 U.S. 1096
O'Connor, Breyer.
Published

C. A. Fed. Cir. Certiorari denied.

Justice O’Connor and Justice Breyer took no part in the consideration or decision of this petition.